-
Elpis Biomed human cell models could potentially replace animal experiments in drug discovery
cphi-online
October 30, 2018
OPTi-OX technology allows the company to produce human cells of unprecedented quality, purity, and consistency.
-
New $2 million programme aims at increasing diversity in cancer research
pharmafile
October 25, 2018
The National Cancer Institute are developing a joint cancer drug discovery and development, and research education programme focused towards the development of treatments...
-
Drug discovery outsourcing market forecast 2017-2025
europeanpharmaceuticalreview
October 24, 2018
A market report has given a complete backdrop analysis of the pharmaceutical drug discovery outsourcing market, including market growth and shares…
-
Corbus nets over 600 endocannabinoid-related compounds, planning to develop 1-2 per year
fiercebiotech
September 21, 2018
The deal includes $250,000 upfront, plus up to $18.4 million in milestone payments for each compound Corbus develops.
-
Oxford regenerative medicine spinout brings on GlaxoSmithKline drug hunter as CSO
fiercebiotech
September 11, 2018
Terstappen will work with OxStem’s scientific founders and principal investigators at the University of Oxford across its six discovery programs.
-
Shanghai ChemPartner closes deal with Quantum
biospectrumasia
August 20, 2018
Michael Hui will remain the Chairman of the Shanghai ChemPartner, and will serve as the Vice Chairman of the Quantum Board of Directors.
-
Suven Life Sciences announces financial results for quarter ending June 30, 2018
financialexpress
August 17, 2018
Suven’s income at INR 1998 mn; PAT at INR 388 Mn for the quarter ended June 2018
-
HitGen Announces Innovative Drug Discovery Research Collaboration with LG Chem by Applying DNA-EncodedTechnology
en-cphi.cn
August 17, 2018
Chengdu, China, August 17, 2018, HitGen Ltd today announced a multi-year major drug discovery research collaboration with LG Chem to identify novel small molecule leads for targets of interest.
-
WuXi AppTec, Insilico unite to integrate AI with Drug Discovery
biospectrumasia
June 13, 2018
WuXi AppTec and Insilico Medicine establish a close strategic collaboration to integrate next-generation artificial intelligence with drug discovery
-
Review of Drugs for Alzheimer’s Disease—Lucky Stars, Fallen Stars and Future Stars of Patients
Erxiao
February 13, 2018
The pharmaceutical giants that entered early in the field have suffered R&D setbacks and quit, but this does not stop other companies from continuing to seek the light of victory.